We at TIEFEENBACHER PHARMACEUTICALS strive to make our high-quality medicines available and affordable to as many people as possible around the world. That´s why we are happy to share that we have successfully prepared the launch of the generic version of Vildagliptin and the combination product Vildagliptin/Metformin in Africa.
Vildagliptin and Vildagliptin/Metformin are diabetes medicines that are used to control the blood glucose (sugar) in adults with type 2 diabetes. The tablets are marketed in South Africa (Vildagliptin 50 mg) and Namibia (Vildagliptin/Metformin 50/1000 mg) by our marketing partner, a well-known South African based pharmaceutical company. The products have been developed in TIEFENBACHER GROUP´s own laboratories in Hyderabad, India, and will be marketed in Europe and further international countries as soon as the patents of the originator products have expired.
For further information about our pharmaceuticals or medical devices please contact TIEFENBACHER PHARMACEUTICALS: info@aet.eu
TIEFENBACHER PHARMACEUTICALS is a part of TIEFENBACHER GROUP – pioneering healthcare since 1963. Please visit us on: www.aet.eu and www.tiefenbachergroup.com
